While Teladoc Health Inc has overperformed by 0.70%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TDOC fell by -50.75%, with highs and lows ranging from $30.41 to $12.53, whereas the simple moving average fell by -31.81% in the last 200 days.
On February 29, 2024, Cantor Fitzgerald started tracking Teladoc Health Inc (NYSE: TDOC) recommending Overweight. A report published by Leerink Partners on February 26, 2024, Initiated its previous ‘Market Perform’ rating for TDOC. DA Davidson also Downgraded TDOC shares as ‘Neutral’, setting a target price of $22 on the company’s shares in a report dated January 17, 2024. Barclays Initiated an Overweight rating on January 03, 2024, and assigned a price target of $26. Stephens initiated its ‘Equal-Weight’ rating for TDOC, as published in its report on April 12, 2023. SVB Securities’s report from February 23, 2023 suggests a price prediction of $34 for TDOC shares, giving the stock a ‘Outperform’ rating. Guggenheim also rated the stock as ‘Neutral’.
Analysis of Teladoc Health Inc (TDOC)
Further, the quarter-over-quarter increase in sales is 2.68%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Teladoc Health Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -10.18% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.65, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and TDOC is recording an average volume of 5.31M. On a monthly basis, the volatility of the stock is set at 4.01%, whereas on a weekly basis, it is put at 3.94%, with a gain of 1.02% over the past seven days. Furthermore, long-term investors anticipate a median target price of $17.23, showing growth from the present price of $12.88, which can serve as yet another indication of whether TDOC is worth investing in or should be passed over.
How Do You Analyze Teladoc Health Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.10%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 71.59% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
TDOC shares are owned by institutional investors to the tune of 71.59% at present.
